| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | 2.37e-05 | 479 | 65 | 9 | GO:0003779 | |
| GeneOntologyCellularComponent | pituitary gonadotropin complex | 1.66e-06 | 8 | 66 | 3 | GO:0061696 | |
| GeneOntologyCellularComponent | lamellipodium | 8.70e-05 | 230 | 66 | 6 | GO:0030027 | |
| MousePheno | abnormal conotruncal ridge morphology | 4.90e-05 | 17 | 60 | 3 | MP:0010585 | |
| MousePheno | abnormal conotruncus morphology | 5.86e-05 | 18 | 60 | 3 | MP:0010583 | |
| Domain | Gonadotropin_bsu_CS | 8.37e-07 | 6 | 66 | 3 | IPR018245 | |
| Domain | Gonadotropin_bsu | 1.46e-06 | 7 | 66 | 3 | IPR001545 | |
| Domain | GLYCO_HORMONE_BETA_2 | 1.46e-06 | 7 | 66 | 3 | PS00689 | |
| Domain | GHB | 1.46e-06 | 7 | 66 | 3 | SM00068 | |
| Domain | GLYCO_HORMONE_BETA_1 | 1.46e-06 | 7 | 66 | 3 | PS00261 | |
| Domain | Glyco_hormone_CN | 1.86e-05 | 15 | 66 | 3 | IPR006208 | |
| Domain | Cys_knot | 1.86e-05 | 15 | 66 | 3 | PF00007 | |
| Domain | MAP7_fam | 7.35e-05 | 4 | 66 | 2 | IPR008604 | |
| Domain | MAP7 | 7.35e-05 | 4 | 66 | 2 | PF05672 | |
| Domain | ZF_FYVE | 3.79e-04 | 40 | 66 | 3 | PS50178 | |
| Domain | - | 1.72e-03 | 67 | 66 | 3 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 1.72e-03 | 67 | 66 | 3 | IPR029034 | |
| Domain | Znf_FYVE_PHD | 1.82e-03 | 147 | 66 | 4 | IPR011011 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 2468994 | ||
| Pubmed | The beta subunit of human chorionic gonadotropin is encoded by multiple genes. | 1.42e-07 | 6 | 68 | 3 | 6194155 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 1371113 | ||
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 6319099 | ||
| Pubmed | The beta chorionic gonadotropin-beta luteinizing gene cluster maps to human chromosome 19. | 1.42e-07 | 6 | 68 | 3 | 6204923 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 2422163 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 6690982 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SHROOM3 ALDH1A2 ABL2 RAPH1 CARMIL1 SVIL PKD1L1 MAP7D2 MICAL3 MGA NEURL4 | 7.77e-07 | 853 | 68 | 11 | 28718761 |
| Pubmed | MAGI2 SHROOM3 MAP7D1 NHSL2 SVIL DIDO1 MGA TNS1 NIPBL NEURL4 MTSS2 | 2.51e-06 | 963 | 68 | 11 | 28671696 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 1820200 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7723844 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 6774259 | ||
| Pubmed | NHSL1 PTPRA RAPH1 TPRN SVIL MICAL3 SLC39A10 CDC25A TNS1 NEURL4 SNX19 | 5.68e-06 | 1049 | 68 | 11 | 27880917 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19523396 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18048458 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10468638 | ||
| Pubmed | Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection. | 1.13e-05 | 3 | 68 | 2 | 11861891 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24778026 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 1688430 | ||
| Pubmed | 1.50e-05 | 407 | 68 | 7 | 12693553 | ||
| Pubmed | The transcription factor GATA4 is required for follicular development and normal ovarian function. | 1.80e-05 | 26 | 68 | 3 | 23769843 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 8202136 | ||
| Pubmed | Identification of a promoter region in the CG beta gene cluster. | 2.25e-05 | 4 | 68 | 2 | 2452822 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 6209613 | ||
| Pubmed | 3.40e-05 | 32 | 68 | 3 | 31913463 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 20417104 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 10618427 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 2424697 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 22911753 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 8543188 | ||
| Pubmed | Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. | 3.75e-05 | 5 | 68 | 2 | 1727547 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 7877975 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 17699734 | ||
| Pubmed | The pleiotropic effects of excessive luteinizing hormone secretion in transgenic mice. | 3.75e-05 | 5 | 68 | 2 | 17710732 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 15569941 | ||
| Pubmed | Developmental hourglass and heterochronic shifts in fin and limb development. | 3.75e-05 | 5 | 68 | 2 | 33560225 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 19647136 | ||
| Pubmed | Expression of the beta subunit of chorionic gonadotropin in transgenic mice. | 3.75e-05 | 5 | 68 | 2 | 7508931 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 9231809 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12960102 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12040011 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12040015 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 10342846 | ||
| Pubmed | Stress levels of glucocorticoids inhibit LHβ-subunit gene expression in gonadotrope cells. | 3.75e-05 | 5 | 68 | 2 | 22851703 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 8784083 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 39158745 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.47e-05 | 861 | 68 | 9 | 36931259 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 33924969 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 24092638 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 14871891 | ||
| Pubmed | AMP-activated protein kinase is a key intermediary in GnRH-stimulated LHβ gene transcription. | 5.62e-05 | 6 | 68 | 2 | 23518923 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 23525221 | ||
| Pubmed | Maximal activity of the luteinizing hormone beta-subunit gene requires beta-catenin. | 5.62e-05 | 6 | 68 | 2 | 17244763 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 10949077 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 21521715 | ||
| Pubmed | Dependence of uterine cyclooxygenase2 expression on luteinizing hormone signaling. | 5.62e-05 | 6 | 68 | 2 | 15814897 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 17569755 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 17350160 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 18431515 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 12746302 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 15451561 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 17371839 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 13679314 | ||
| Pubmed | Increases in luteinizing hormone are associated with declines in cognitive performance. | 5.62e-05 | 6 | 68 | 2 | 17376589 | |
| Pubmed | Luteinizing hormone promotes gonadal tumorigenesis in inhibin-deficient mice. | 5.62e-05 | 6 | 68 | 2 | 18657590 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 12193554 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 18308464 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 22508984 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 25617744 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 14585811 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 26018251 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 20546829 | ||
| Pubmed | HOXA9 ZSWIM8 SETDB2 DCAF6 MAP7D1 SALL2 TPRN MGA DCAF5 ZNF518A | 5.97e-05 | 1116 | 68 | 10 | 31753913 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 10319325 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 26789235 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 12429736 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 21658369 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 24706813 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 20068010 | ||
| Pubmed | Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project. | 7.86e-05 | 7 | 68 | 2 | 19929279 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 12748296 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 6582507 | ||
| Pubmed | Regulation of LH/FSH expression by secretoglobin 3A2 in the mouse pituitary gland. | 7.86e-05 | 7 | 68 | 2 | 24514953 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 34681844 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 22865884 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 21108604 | ||
| Pubmed | Ovulation involves the luteinizing hormone-dependent activation of G(q/11) in granulosa cells. | 7.86e-05 | 7 | 68 | 2 | 23836924 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 17299135 | ||
| Pubmed | Evidence for cross-talk between the LH receptor and LH during implantation in mice. | 7.86e-05 | 7 | 68 | 2 | 23464498 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 20797425 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 36077179 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 19474061 | ||
| Pubmed | Anterior pituitary development: short tales from dwarf mice. | 7.86e-05 | 7 | 68 | 2 | 1505020 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 9501026 | ||
| Pubmed | Stress rapidly suppresses in vivo LH pulses and increases activation of RFRP-3 neurons in male mice. | 7.86e-05 | 7 | 68 | 2 | 30382693 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 26076042 | ||
| Pubmed | 8.94e-05 | 44 | 68 | 3 | 23070814 | ||
| Pubmed | PITPNM1 MAGI2 NHSL1 MAP7D1 PTPRA CARMIL1 VCAN SVIL MAP7D2 MICAL3 TNS1 | 9.77e-05 | 1431 | 68 | 11 | 37142655 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 20702576 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 28961951 | ||
| Cytoband | 19q13.32 | 1.87e-04 | 74 | 68 | 3 | 19q13.32 | |
| Cytoband | Xq13.1 | 2.33e-03 | 48 | 68 | 2 | Xq13.1 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 3.00e-06 | 86 | 68 | 5 | M39248 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.57e-07 | 172 | 68 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.25e-07 | 179 | 68 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-07 | 181 | 68 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-07 | 181 | 68 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-07 | 185 | 68 | 6 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-07 | 185 | 68 | 6 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 156 | 68 | 5 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 156 | 68 | 5 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 188 | 68 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 188 | 68 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.15e-05 | 193 | 68 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.24e-05 | 196 | 68 | 5 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 197 | 68 | 5 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 6.80e-05 | 143 | 68 | 4 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 149 | 68 | 4 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 149 | 68 | 4 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-05 | 153 | 68 | 4 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.84e-05 | 153 | 68 | 4 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.53e-05 | 156 | 68 | 4 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.53e-05 | 156 | 68 | 4 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 158 | 68 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 158 | 68 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 159 | 68 | 4 | 210ac7fa89514a84f38d9f42254e38fbc2bc5f42 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 160 | 68 | 4 | c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 160 | 68 | 4 | 79e833c904c762434993b5ec9d5e3540e695fad3 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.05e-04 | 160 | 68 | 4 | 04714d0b9bad4c11fa193ed168e2d84a4df39e2e | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 166 | 68 | 4 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | 17fb9426eeea407b26fb895b8397faca95b7552d | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | a61b39884851384cffd430079040546d125b2b40 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 1.27e-04 | 168 | 68 | 4 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 168 | 68 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 1.39e-04 | 172 | 68 | 4 | a66402d15853f0c9e3d06394ff9ac08d1da128ff | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 175 | 68 | 4 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 177 | 68 | 4 | 9d2d70d53b919fed3328812889a55e5e1a0759de | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.58e-04 | 178 | 68 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 179 | 68 | 4 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.62e-04 | 179 | 68 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 180 | 68 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.65e-04 | 180 | 68 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 182 | 68 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.72e-04 | 182 | 68 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.72e-04 | 182 | 68 | 4 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 1.80e-04 | 184 | 68 | 4 | c294cd421f277992b56ae9c40b8f3948e33148fe | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Immature_B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.80e-04 | 184 | 68 | 4 | e6669a1b7ea7e4f8e094add5117689470019d85d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-04 | 186 | 68 | 4 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 188 | 68 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 188 | 68 | 4 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 188 | 68 | 4 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 189 | 68 | 4 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 189 | 68 | 4 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-04 | 191 | 68 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.07e-04 | 191 | 68 | 4 | 47f20686001f945bc31d5a0b974958e4009edb34 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.07e-04 | 191 | 68 | 4 | 14b11244c330cc4fe897253aaaf0df80caa01a55 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.11e-04 | 192 | 68 | 4 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-04 | 192 | 68 | 4 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.16e-04 | 193 | 68 | 4 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-04 | 194 | 68 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 194 | 68 | 4 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 194 | 68 | 4 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.24e-04 | 195 | 68 | 4 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 023477a499a2c190f363cfdbc9d9c646733a6541 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.29e-04 | 196 | 68 | 4 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-04 | 197 | 68 | 4 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-04 | 197 | 68 | 4 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.33e-04 | 197 | 68 | 4 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.33e-04 | 197 | 68 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | 824461cf44098440ba8bc0df96735423ac65bda1 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | 863765ccc0205dc28864dae85af339c283194c96 | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 2.38e-04 | 198 | 68 | 4 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 199 | 68 | 4 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 2.42e-04 | 199 | 68 | 4 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 199 | 68 | 4 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 199 | 68 | 4 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-04 | 200 | 68 | 4 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.47e-04 | 200 | 68 | 4 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| Disease | congenital diaphragmatic hernia (is_implicated_in) | 2.95e-05 | 4 | 66 | 2 | DOID:3827 (is_implicated_in) | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 3.36e-05 | 28 | 66 | 3 | OBA_2045139 | |
| Disease | level of Phosphatidylcholine (15:0_18:1) in blood serum | 4.91e-05 | 5 | 66 | 2 | OBA_2045064 | |
| Disease | 1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) measurement | 7.35e-05 | 6 | 66 | 2 | EFO_0800471 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) measurement | 7.35e-05 | 6 | 66 | 2 | EFO_0800444 | |
| Disease | level of Phosphatidylcholine (16:0_18:1) in blood serum | 7.35e-05 | 6 | 66 | 2 | OBA_2045070 | |
| Disease | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement | 7.35e-05 | 6 | 66 | 2 | EFO_0020014 | |
| Disease | sleep duration, triglyceride measurement | 8.87e-05 | 104 | 66 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement | 1.03e-04 | 7 | 66 | 2 | EFO_0800470 | |
| Disease | 1-oleoyl-2-linoleoyl-GPE (18:1/18:2) measurement | 1.03e-04 | 7 | 66 | 2 | EFO_0800443 | |
| Disease | level of Phosphatidylcholine (17:0_18:2) in blood serum | 1.03e-04 | 7 | 66 | 2 | OBA_2045086 | |
| Disease | level of Phosphatidylcholine (16:0_22:6) in blood serum | 1.03e-04 | 7 | 66 | 2 | OBA_2045080 | |
| Disease | cholesteryl ester 20:4 measurement | 1.33e-04 | 44 | 66 | 3 | EFO_0010348 | |
| Disease | 2-arachidonoyl-GPE (20:4) measurement | 1.37e-04 | 8 | 66 | 2 | EFO_0800260 | |
| Disease | 1-linoleoyl-GPE (18:2) measurement | 1.37e-04 | 8 | 66 | 2 | EFO_0800247 | |
| Disease | immature platelet measurement | 1.49e-04 | 119 | 66 | 4 | EFO_0803541 | |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 1.76e-04 | 9 | 66 | 2 | EFO_0800248 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement | 1.76e-04 | 9 | 66 | 2 | EFO_0800409 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement | 1.76e-04 | 9 | 66 | 2 | EFO_0800403 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) measurement | 1.76e-04 | 9 | 66 | 2 | EFO_0800272 | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 2.19e-04 | 10 | 66 | 2 | EFO_0800608 | |
| Disease | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement | 2.19e-04 | 10 | 66 | 2 | EFO_0800402 | |
| Disease | cholesteryl ester 22:5 measurement | 2.19e-04 | 10 | 66 | 2 | EFO_0021444 | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 2.68e-04 | 11 | 66 | 2 | EFO_0800269 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 2.68e-04 | 11 | 66 | 2 | OBA_2045123 | |
| Disease | interleukin-6 measurement, response to stimulus | 2.68e-04 | 11 | 66 | 2 | EFO_0004810, GO_0050896 | |
| Disease | triacylglycerol 53:2 measurement | 3.21e-04 | 12 | 66 | 2 | EFO_0021484 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 3.21e-04 | 12 | 66 | 2 | EFO_0800466 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 3.21e-04 | 12 | 66 | 2 | OBA_2045157 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.21e-04 | 12 | 66 | 2 | C0023485 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 3.21e-04 | 12 | 66 | 2 | OBA_2045074 | |
| Disease | human Chorionic Gonadotropin measurement | 3.78e-04 | 13 | 66 | 2 | EFO_0008156 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 3.78e-04 | 13 | 66 | 2 | OBA_2045174 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 3.78e-04 | 13 | 66 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 3.78e-04 | 13 | 66 | 2 | OBA_2045082 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 4.41e-04 | 14 | 66 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 4.41e-04 | 14 | 66 | 2 | OBA_2045142 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 4.41e-04 | 14 | 66 | 2 | OBA_2045143 | |
| Disease | acute lymphoblastic leukemia | 4.42e-04 | 66 | 66 | 3 | EFO_0000220 | |
| Disease | Situs ambiguus | 5.08e-04 | 15 | 66 | 2 | C0266642 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 5.08e-04 | 15 | 66 | 2 | EFO_0800508 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 5.08e-04 | 15 | 66 | 2 | OBA_2045131 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 5.08e-04 | 15 | 66 | 2 | OBA_2045165 | |
| Disease | phosphatidate measurement | 5.08e-04 | 15 | 66 | 2 | EFO_0020047 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 5.08e-04 | 15 | 66 | 2 | OBA_2045067 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 5.79e-04 | 16 | 66 | 2 | OBA_2045090 | |
| Disease | laryngeal squamous cell carcinoma | 6.56e-04 | 17 | 66 | 2 | EFO_0006352 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 6.56e-04 | 17 | 66 | 2 | OBA_2045063 | |
| Disease | urinary albumin to creatinine ratio | 7.04e-04 | 179 | 66 | 4 | EFO_0007778 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 7.37e-04 | 18 | 66 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 7.37e-04 | 18 | 66 | 2 | OBA_2045065 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 8.22e-04 | 19 | 66 | 2 | OBA_2045140 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 8.22e-04 | 19 | 66 | 2 | EFO_0802076 | |
| Disease | diacylglycerol 38:5 measurement | 8.22e-04 | 19 | 66 | 2 | EFO_0020067 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 9.12e-04 | 20 | 66 | 2 | OBA_2045071 | |
| Disease | liver fibrosis measurement | 9.58e-04 | 86 | 66 | 3 | EFO_0010576 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 1.01e-03 | 21 | 66 | 2 | OBA_2045083 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.06e-03 | 200 | 66 | 4 | EFO_0004611, EFO_0020945 | |
| Disease | phosphatidylserines measurement | 1.21e-03 | 23 | 66 | 2 | EFO_0020049 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 1.32e-03 | 24 | 66 | 2 | OBA_2045136 | |
| Disease | Adenoid Cystic Carcinoma | 1.48e-03 | 100 | 66 | 3 | C0010606 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 1.55e-03 | 26 | 66 | 2 | OBA_2045087 | |
| Disease | Stevens-Johnson Syndrome | 2.06e-03 | 30 | 66 | 2 | C0038325 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 2.06e-03 | 30 | 66 | 2 | EFO_0000341, EFO_0004351 | |
| Disease | immature platelet fraction | 2.15e-03 | 114 | 66 | 3 | EFO_0009187 | |
| Disease | triacylglycerol 54:3 measurement | 2.20e-03 | 31 | 66 | 2 | EFO_0010421 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPGTTSAQPPSEEER | 116 | Q9UKU6 | |
| SRTDSPIPPFGESEQ | 31 | A8MT66 | |
| GDDTSFDPNPKPVSR | 181 | Q6PI77 | |
| SKSSTLGQEERPPEP | 1451 | Q8WWN8 | |
| EPPASVPSKQSGRSD | 136 | A6NEN9 | |
| TRPPTVEDKEAFGPQ | 1291 | P13611 | |
| GKPTASDDTSKPFPR | 766 | P42684 | |
| PYKEEESISPGTPRS | 146 | Q86TB3 | |
| SPFDPTTEQGPQIDK | 351 | O94788 | |
| DDPRFQDSSSSKAPP | 161 | A6NKQ9 | |
| SSVQPPEGDSETKAP | 526 | Q58WW2 | |
| RTPSSEEISPTKFPG | 26 | Q15311 | |
| RGKDSVVEFPSPPSD | 1056 | Q70E73 | |
| GSPPETQESKRPSSL | 316 | O95755 | |
| RPVSDTTEPSSPEGK | 341 | Q8IXS6 | |
| PSEDASNGREPKAPT | 616 | Q9HCC9 | |
| DPTEEATPTPFGKDQ | 1236 | Q9H2M9 | |
| SVGSSDPENKDPRPL | 756 | Q9C0D6 | |
| TLFSKGPEDTSQPSP | 4136 | Q8WXI7 | |
| SSAPSQGKERRPDSP | 1636 | Q7RTP6 | |
| EGPLAPSTDEPSQKT | 21 | Q8WZ60 | |
| SSFPDSTEAFDPRKP | 726 | Q86UL8 | |
| DFTGPPTFPKRSSEN | 691 | Q96T17 | |
| PPEPQSFASKTGSET | 1906 | Q8IWI9 | |
| AERTPTGEKSPNSPR | 26 | A6NMX2 | |
| DGKVFPNPESERNSP | 891 | Q8WW38 | |
| DDPRFQASSSSKAPP | 131 | P0DN87 | |
| KDTRPPFTNSGQPES | 1036 | Q5SYE7 | |
| EGPPEFDKSSTIPRN | 506 | Q765P7 | |
| SPPVDREKQPSEGAF | 161 | P31269 | |
| PSSGEQKSRPDSPRV | 881 | Q6KC79 | |
| DTFKEETPRTPSNGP | 731 | Q96JK2 | |
| TGRPSKSAATEPEDP | 96 | Q86XE3 | |
| QVSGKESPPVSDTPD | 11 | Q13422 | |
| RGAPNKEETPATESP | 31 | Q02818 | |
| PTPEDSPSLETGSRQ | 236 | Q9BQQ3 | |
| PPGKESSVKRTFPED | 431 | Q8WWV6 | |
| DDPRFQDSSSSKAPP | 131 | P0DN86 | |
| SFSRSPPPGKQDSSD | 11 | Q16520 | |
| KSFDPSAREPPGSTA | 1326 | Q9BTC0 | |
| GELSPEQPSFEPTKN | 91 | O60427 | |
| PPQEESPSSEAKSRG | 81 | Q3KQU3 | |
| EKITDFEGQPPTPRD | 111 | Q8N7A1 | |
| SDKERDGQSSPQPSP | 1306 | Q5VZK9 | |
| PDNSIRFKPPLEGSE | 926 | Q5T890 | |
| TSTGLSPFPRKDDPT | 991 | Q9Y467 | |
| ITPSERGEPSNEPST | 201 | Q9ULF5 | |
| PPDTDTPGFAEENRT | 216 | Q06136 | |
| SERFSPQPGTSPEKV | 1701 | Q8TDX9 | |
| STRLEESEGTQPPSP | 1086 | Q96JN8 | |
| PERSQEESPPGSTKR | 276 | P30304 | |
| TPETFPPSGNSDSKD | 131 | P18433 | |
| SGSSPNPFSEDVKRP | 26 | Q6NUM9 | |
| GTPYPDPLEQSSDKR | 121 | Q5TD94 | |
| PGSPTEIPFSSKQED | 31 | Q96KW9 | |
| RSPEDPSRNEDFGKP | 466 | O95425 | |
| TFRSSDEATKPTPNP | 161 | Q5HYW2 | |
| GATAEPPESPQTRDK | 946 | P98174 | |
| SEDPEGPRPSFNKLS | 1561 | Q8TF72 | |
| SEAQPPGKPSTEARS | 266 | O00562 | |
| SESVTPEDNDGFKPP | 511 | Q96T68 | |
| SSSERENSPPPRGSK | 456 | Q6ZMY6 | |
| GPRAQDSEPKSFSAP | 1036 | Q9HBL0 | |
| PNRDPTDESKDSSGP | 1571 | Q9HBL0 | |
| PESESEKPTPLSTGQ | 386 | Q6AHZ1 | |
| AFPRSEPQSPTEELS | 691 | Q92543 | |
| PTEGFTEKNVPESSP | 1076 | A7E2V4 | |
| TSTNDSFEIRPAPKP | 291 | Q4KMQ1 | |
| QSPKRPPEDFETPSG | 166 | Q8WUA4 | |
| FPEPKSSTQAPESQE | 646 | Q96LC7 | |
| SQEAPSFQGTESPKP | 166 | Q6PJF5 | |
| RLGSEEPSKEPSSPS | 531 | Q8NFW9 |